| Case number | AUTH/3282/11/19 |
|---|---|
| Case reference | VIIV/DIRECTOR v GILEAD |
| Complainant | ViiV Healthcare UK Ltd; also taken up in the name of the Director |
| Respondent/company | Gilead Sciences Europe Ltd |
| Product(s) | Biktarvy (bictegravir/emtrictabine/tenofovir); Juluca (dolutegravir/rilpivirne) |
| Material/channel | UK-accessible website; password-protected health professional pages of Gilead’s hiv.eu website |
| Key issue | Continued publication of a claim previously ruled in breach after an undertaking was signed (breach of undertaking) |
| Dates (received/completed if stated) | Complaint received 21 November 2019; Case completed 29 January 2020 |
| Appeal | Related claim was subject of an unsuccessful appeal in Case AUTH/3137/12/18; Appeal Board ruled breach on 9 October 2019 |
| Code year | Not stated |
| Breaches/clauses | Clauses 29, 9.1 and 2 |
| Sanctions | No explicit additional sanctions stated beyond the required undertaking/corrective actions described in the report |
Download the full case report (PDF):
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
No explicit additional sanctions stated beyond the required undertaking/corrective actions described in the report
Why this matters: Undertakings underpin self-regulation. If material ruled in breach remains live after an undertaking is signed, it undermines confidence in compliance controls and can escalate a matter into a Clause 2 (industry discredit) issue.
Where teams typically slip up (interpretation):
The control that would have prevented it: A formal post-ruling/undertaking takedown SOP requiring a complete inventory-based sweep of all owned digital properties (including gated HCP areas) with evidence of removal and a second-person verification before confirming completion.
What I’d check in the job bag:
What the sanctions tell you (interpretation):
3 questions to ask your team this week:
One real case. One key lesson. Every week — free.